Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 7723432
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 7714088
Poly(ethylene glycol) derivatives with proximal reactive groups
granted -
US 7714114
Conjugates of an EPO moiety and a polymer
granted -
US 7674879
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7662365
Polymer conjugates of opioid antagonists
granted -
US 7659361
Maleamic acid polymer derivatives and their bioconjugates
granted -
US 7655747
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
granted -
US 7608253
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
granted -
US 7598338
Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
granted -
US 7589157
Multi-arm block copolymers as drug delivery vehicles
granted -
US 7582284
Particulate materials
granted -
US 7579444
Polymer-factor IX moiety conjugates
granted -
US 7569214
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
granted -
US 7547509
Cyanovirin variant-polymer conjugates
granted -
US 7544738
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 7528202
Poly (ethylene glycol) derivatives with proximal reactive groups
granted -
US 7511094
Water-soluble polymer alkanals
granted -
US 7511095
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
granted -
US 7481212
Increased dosage metered dose inhaler
granted -
US 7482024
Compositions comprising an active agent
granted -
US 7473433
Pulmonary delivery of polyene antifungal agents
granted -
US 7449201
Storage stable power compositions of interleukin-4 receptor
granted -
US 7432330
Hydrolytically stable maleimide-terminated polymers
granted -
US 7432331
Hydrolytically stable maleimide-terminated polymers
granted -
US 7419600
Method for purifying a branched water-soluble polymer
granted -
US 7405266
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7393544
Dispersion for pulmonary delivery of a bioactive agent
granted -
US 7378469
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 7368102
Pulmonary delivery of aminoglycosides
granted -
US 7329721
Maleamic acid polymer derivatives and their bioconjugates
granted -
US 7326691
Compositions comprising amphotericin B, methods, and systems
granted -
US 7316811
Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles
granted -
US 7312301
Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
granted -
US 7306787
Engineered particles and methods of use
granted -
US 7300919
Pulmonary delivery of active fragments of parathyroid hormone
granted -
US 7265186
Multi-arm block copolymers as drug delivery vehicles
granted -
US 7223803
Polyethylene (glycol) derivatives with proximal reactive groups
granted -
US 7214366
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7208145
Polymeric reagents comprising a ketone or a related functional group
granted -
US 7205380
Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7199223
Polymer-factor VIII moiety conjugates
granted -
US 7172768
Storage stable powder compositions of interleukin-4 receptor
granted -
US 7157546
Water-soluble polymer alkanals
granted -
US 7150766
Method of particle formation
granted -
US 7141236
Methods and compositions for delivering macromolecules to or via the respiratory tract
granted -
US 7138141
Dispersible macromolecule compositions and methods for their preparation and use
granted -
US 7115280
Particle formation methods and their products
granted -
US 7112341
Pulmonary administration of dry powder formulations for treating infertility
granted
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory